Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Scott M Matson, Yet H Khor
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
10.1056/nejmoa1113354 · 2012
Cyclophosphamide versus placebo in scleroderma lung disease
10.1056/nejmoa055120 · 2006
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
10.1016/s2213-2600(22)00359-9 · 2023
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
10.1016/s2213-2600(16)30152-7 · 2016
Treatment outcomes for rheumatoid arthritis associated interstitial lung disease; a real-world, multisite study of the impact of immunosuppression on pulmonary function trajectory
10.1016/j.chest.2022.11.035 · 2023
Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohorts
10.1136/thorax-2024-222367 · 2025
Role of radiographic fibrosis extent in identifying immunomodulatory treatment response in hypersensitivity pneumonitis
10.1016/j.chest.2025.12.007 · 2026
Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis
10.1164/rccm.201809-1646oc · 2019
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis
10.1183/13993003.02872-2020 · 2021
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
10.1183/13993003.00441-2023 · 2023
Azathioprine response in patients with fibrotic connective tissue disease–associated interstitial lung disease
10.1016/j.rmed.2016.11.007 · 2016
Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis
10.1016/j.chest.2016.10.029 · 2017
Mycophenolate and azathioprine in fibrotic interstitial lung disease
10.1093/ajrccm/aamag362 · 2026
No additional external references are available.